|
1
|
Nicolaides AN, Allegra C, Bergan J,
Bradbury A, Cairols M, Carpentier P, Comerota A, Delis C, Eklof B,
Fassiadis N, et al: Management of chronic venous disorders of the
lower limbs guidelines according to scientific evidence. Int
Angiol. 27:1–59. 2008.PubMed/NCBI
|
|
2
|
Zolotukhin IA, Seliverstov EI, Shevtsov
YN, Avakiants IP, Nikishkov AS, Tatarintsev AM and Kirienko AI:
Prevalence and risk factors for chronic venous disease in the
general Russian population. Eur J Vasc Endovasc Surg. 54:752–758.
2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Feodor T, Baila S, Mitea I, Branisteanu D
and Vittos O: Epidemiology and clinical characteristics of chronic
venous disease in Romania. Exp Ther Med. 17:1097–1105.
2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Rabe E, Regnier C, Goron F, Salmat G and
Pannier F: The prevalence, disease characteristics and treatment of
chronic venous disease: An international web-based study. J Comp
Eff Res. 9:1205–1218. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Patel SK and Surowiec SM: Venous
Insufficiency. In: StatPearls [Internet]. StatPearls Publishing,
Treasure Island, FL, 2021.
|
|
6
|
Ashorobi D, Ameer MA and Fernandez R:
Thrombosis. In: StatPearls [Internet]. StatPearls Publishing,
Treasure Island, FL, 2021.
|
|
7
|
Yau JW, Teoh H and Verma S: Endothelial
cell control of thrombosis. BMC Cardiovasc Disord.
15(130)2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hotoleanu C: Association between obesity
and venous thromboembolism. Med Pharm Rep. 93:162–168.
2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Iancu GM, Ocneanu A and Rotaru M:
Hydroxyurea-induced superinfected ulcerations: Two case reports and
review of the literature. Exp Ther Med. 20(191)2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Fortin LJ and Genest J Jr: Measurement of
homocyst(e)ine in the prediction of arteriosclerosis. Clin Biochem.
28:155–162. 1995.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Tinelli C, Di Pino A, Ficulle E, Marcelli
S and Feligioni M: Hyperhomocysteinemia as a risk factor and
potential nutraceutical target for certain pathologies. Front Nutr.
6(49)2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Cattaneo M: Hyperhomocysteinemia and
venous thromboembolism. Semin Thromb Hemost. 32:716–723.
2006.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Brustolin S, Giugliani R and Felix TM:
Genetics of homocysteine metabolism and associated disorders. Bra J
Med Biol Res. 4:1–7. 2010.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Son P and Lewis L: Hyperhomocysteinemia.
In: StatPearls [Internet]. StatPearls Publishing, Treasure Island,
FL, 2020.
|
|
15
|
Zegarra TI and Tadi P: CEAP Classification
of Venous Disorders. In: StatPearls [Internet]. StatPearls
Publishing, Treasure Island, FL, 2021.
|
|
16
|
Hantusch B: Morphological and functional
characteristics of blood and lymphatic vessels. In: Fundamentals of
Vascular Biology. Learning Materials in Biosciences. Geiger M (ed).
Springer, Cham, pp1-43, 2019.
|
|
17
|
Herouy Y: The role of matrix
metalloproteinases (MMPs) and their inhibitors in venous leg ulcer
healing. Phebolymphology. 44:31–267. 2004.
|
|
18
|
Barbu A, Neamțu B, Zăhan M, Iancu GM,
Bacila C and Mireșan V: Current trends in advanced alginate-based
wound dressings for chronic Wounds. J Pers Med.
11(890)2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ali MM, Mahmoud AM, Le Master E, Levitan I
and Phillips SA: Role of matrix metalloproteinases and histone
deacetylase in oxidative stress-induced degradation of the
endothelial glycocalyx. Am J Physiol Heart Circ Physiol.
316:H647–H663. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Brattström L and Wilcken DE: Homocysteine
and cardiovascular disease: Cause or effect? Am J Clin Nutr.
72:315–323. 2000.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Sule AA, Chin TJ and Khien LH: Recurrent
unprovoked venous thrombembolism in a young female patient with
high levels of homocysteine. Int J Angiol. 21:95–98.
2012.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Bolal M, Ates I, Demir BF, Altay M, Turhan
T and Yilmaz N: The relationship between homocysteine and
autoimmune subclinical hypothyroidism. Int J Med Biochem. 3:1–7.
2020.
|
|
23
|
Hasan T, Arora R, Bansal AK, Bhattacharya
R, Sharma GS and Sigh LR: Disturbed homocysteine metabolism in
associated with cancer. Exp Mol Med. 51:1–13. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Lovčić V, Klobučić M, Bašić-Jukić N and
Lovčić P: Is hyperhomocysteinemia approaching traditional risk
factors for cardiovascular diseases? Acta Clin Croat. 45 (Suppl
1):S65–S72. 2006.
|
|
25
|
Elian V, Cioca G, Pantea-Stoian A,
Dobjanschi C and Serafinceanu C: Metabolic syndrome and chronic
kidney disease: Pathogenic, clinical, and therapeutic correlations.
In: Proceedings of the 1st International Conference on
Interdisciplinary Management of Diabetes Mellitus and its
Complications (INTERDIAB), Bucharest, 2015.
|
|
26
|
Papatheodorou L and Weiss N: Vascular
oxidant stress and inflammation in hyperhomocysteinemia. Antioxid
Redox Signal. 9:1941–1958. 2007.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Esfahani M, Movahedian A, Baranchi M and
Goodarzi MT: Adiponectin: An adipokine with protective features
against metabolic syndrome. Iran J Basic Med Sci. 18:430–442.
2015.PubMed/NCBI
|
|
28
|
Undas A, Brozek J and Szczeklik A:
Homocysteine and thrombosis: From basic science to clinical
evidence. Thromb Haemost. 94:907–915. 2005.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Samonakis DN, Oustamanolakis P, Manousou
P, Kouroumalis EA and Burroughs AK: Klippel-Trenaunay syndrome,
pregnancy and the liver: An unusual interplay. Ann Gastroenterol.
25:365–367. 2012.PubMed/NCBI
|
|
30
|
Rotaru M and Iancu GM:
Klippel-Trenaunay-Weber syndrome. Acta Medica Transilvanica.
2:265–267. 2010.
|
|
31
|
den Heijer M, Willems HPJ, Blom HJ,
Gerrits WBJ, Cattaneo M, Eichinger S, Rosendaal FR and Bos GMJ:
Homocysteine lowering by B vitamins and the secondary prevention of
deep vein thrombosis and pulmonary embolism: A randomized,
placebo-controlled, double-blind trial. Blood. 109:139–144.
2007.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Ray JG: Meta-analysis of
hyperhomocysteinemia as a risk factor for venous thromboembolic
disease. Arch Intern Med. 158:2101–2106. 1998.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ganguly P and Alam SF: Role of
homocysteine in the development of cardiovascular disease. Nutr J.
14(6)2015.PubMed/NCBI View Article : Google Scholar
|
